Ace pentru prelevarea țesuturilor moi
Information about customer
Title
IMSP Institutul Oncologic
IDNO
1003600151023
Address
MOLDOVA,
locality,
str. Testemitanu, 30,
MD 2025
The contact person
Adam Ana,
aniusha_adam@mail.ru
Purchase data
ID
ocds-b3wdp1-MD-1663149846783
Title
Ace pentru prelevarea țesuturilor moi
Note
CPV Code
33100000-1 - Echipamente medicale
Rationale
List of funding sources
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1663149847639
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1663939735145
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1667814433731
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1667814433587
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1668163986445
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1668163986296
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670336512311
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670336513162
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670336512979
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670336512407
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670336512765
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670336512577
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670481430520
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670481431188
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670481430950
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670481430138
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670481430746
IBAN
None
Funding source cost
62000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663149846783-FS-1670481430309
IBAN
None
Status Planning
Start the procedure:
1 Jan 2022
1 Jan 2023
Date of publication: 14 Sep 2022 13:05
Date of last modifications: 20 Dec 2022 18:35